Clinical Decision Support Tool Published by AGA for Crohn’s Disease Physicians

Clinical Decision Support Tool Published by AGA for Crohn’s Disease Physicians
The American Gastroenterologial Association (AGA) recently created a clinical decision tool to help gastroenterologists both identify and manage Crohn's disease in their patients. “Identification, Assessment, and Initial Medical Treatment in Crohn’s Disease Clinical Decision Support Tool” is the result of expert work, using an algorithm with the purpose of unifying the treatment for the heterogeneous disease, which was recently published in the official journal of the AGA, Gastroenterology. “As health care systems move toward providing better quality care, it is important for gastroenterologists to have clinical support tools that will help them treat underlying disease, as well as the whole person,” explained one the author of the clinical decision tool, William J. Sandborn, MD, from the division of gastroenterology, of the Inflammatory Bowel Disease Center, at the University of California, San Diego. “This clinical support tool represents a big step forward for the treatment of Crohn’s disease and was created using a rigorous review process.” The group of researchers working on the clinical decision tool started by reviewing the latest data on the disease in order to create the algorithm to support physicians in evaluating their patients for active inflammation and comorbidities, as well as risk-stratification and application of appropriate therapies. The researchers based their work mainly on the AGA document "Guideline on the Use of Thiopurines, Methotrexate, and Anti-TNF-a Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn’s Disease." “With the well-justified push toward providing better value in health care, we will ultimately need to have clinical support tools that focus on treating th
Subscribe or to access all post and page content.